Pfizer
HealthA new batch of COVID pills are in focus as daily life reopens. Here’s how the treatments work—and how well
By Jason Gale, John Lauerman and BloombergFebruary 15, 2022
HealthChina’s approval of Pfizer’s antiviral COVID pill may be a turning point in its pandemic strategy
By Grady McGregorFebruary 15, 2022
By Carmela ChirinosFebruary 12, 2022
By Fiona Rutherford and BloombergFebruary 11, 2022
HealthScientists said we’d take annual COVID jabs like flu shots. Now Fauci says it might be only every 5 years
By Sophie MellorFebruary 9, 2022
FinanceThe COVID bump looks over for Pfizer as 2022 forecast falls short of Wall Street estimates, stock drops
By Riley Griffin and BloombergFebruary 8, 2022
HealthModerna wouldn’t share its vaccine technology, so South Africa and the WHO made a COVID jab based on it anyway
By David MeyerFebruary 4, 2022
By Matthew Heimer and Scott DeCarloFebruary 2, 2022
By Andrew MarquardtFebruary 1, 2022
By Ian Fisher and BloombergJanuary 31, 2022
PoliticsPfizer CEO Albert Bourla and Europe’s leaders negotiated a vaccine megadeal by private text. Now those messages may come out
By David MeyerJanuary 28, 2022
By Fiona Rutherford and BloombergJanuary 21, 2022
By Christiaan HetznerJanuary 21, 2022
Most Popular
